Analyst Ratings for Avadel Pharmaceuticals (AVDL)
AVDL Rating Summary
AVDL Price Target Summary
- Highest: $29.00 (Oppenheimer)
- Lowest: $21.00 (UBS)
- Average: $23.67
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$23.67 (+30.8%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 86%
Avg. $ Target:
$23.67 (+30.8%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 86%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/6/2024 | UBS | Ashwani Verma | New Coverage | Buy (N/A) |
21.00 (N/A) |
14.69 (18.09) |
23.14% | Details |
| 11/30/2022 | Jefferies » Updated 3/31/2023 |
Chris Howerton | Upgrade | Buy (Hold) |
12.00 (10.00) |
7.84 (18.09) |
130.74% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
